Search Results - "Schümann, Friederike"

Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum by Schümann, Friederike, Schmitt, Oliver, Wree, Andreas, Hawlitschka, Alexander

“…In Parkinson's disease, hypercholinism in the striatum occurs, with the consequence of disturbed motor functions. Direct application of Botulinum neurotoxin-A…”
Get full text

The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption by Silbernagel, Günther, Steiner, Lars K., Hollstein, Tim, Fauler, Günter, Scharnagl, Hubert, Stojakovic, Tatjana, Schumann, Friederike, Bölükbasi, Bediha, März, Winfried, Steinhagen-Thiessen, Elisabeth, Laufs, Ulrich, Kassner, Ursula

“…Very few studies have investigated the interrelations between proprotein convertase subtilisin/kexin type 9 (PCSK9) metabolism, cholesterol synthesis, and…”
Get full text

Online Learning for Wearable EEG-Based Emotion Classification by Moontaha, Sidratul, Schumann, Franziska Elisabeth Friederike, Arnrich, Bert

“…Giving emotional intelligence to machines can facilitate the early detection and prediction of mental diseases and symptoms. Electroencephalography (EEG)-based…”
Get full text

Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®) by Kamm, Christoph, Schümann, Friederike, Mix, Eilhard, Benecke, Reiner

“…Highlights • We report the second dystonia patient worldwide who developed secondary treatment failure under therapy with Xeomin. • This patient had been…”
Get full text

Sometimes less is more – hypoalphalipoproteinemia: A case report by Schumann, Friederike, Kassner, Ursula, Steinhagen-Thiessen, Elisabeth

Get full text

The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors by Blanchard, Valentin, Chemello, Kévin, Hollstein, Tim, Hong-Fong, Clément Chong, Schumann, Friederike, Grenkowitz, Thomas, Nativel, Brice, Coassin, Stefan, Croyal, Mikaël, Kassner, Ursula, Lamina, Claudia, Steinhagen-Thiessen, Elisabeth, Lambert, Gilles

“…Abstract Aims Lipoprotein (a) [Lp(a)] is a lipoprotein species causatively associated with atherosclerosis. Unlike statins, PCSK9 inhibitors (PCSK9i) reduce…”
Get full text

PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 Weeks by Hollstein, Tim, Kassner, Ursula, Grenkowitz, Thomas, Schumann, Friederike, Bobbert, Thomas, Steinhagen-Thiessen, Elisabeth

“…Aims Several the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high cardiovascular risk who are…”
Get full text

Statin intolerance and statin-associated muscular pain by Stürzebecher, Paulina Elena, Schumann, Friederike, Kassner, Ursula, Laufs, Ulrich

“…Statins are among the best studied drugs. Due to the extensive evidence regarding efficacy and safety, they are the cornerstone of lipid-lowering therapy…”
Get full text

Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation by Schumann, Friederike, Kassner, Ursula, Spira, Dominik, Zimmermann, Felix F., Bobbert, Thomas, Steinhagen-Thiessen, Elisabeth, Hollstein, Tim

“…•Elevated lipoprotein(a) is an established risk factor for cardiovascular disease.•Lipoprotein apheresis is the only approved treatment to significantly lower…”
Get full text

PCSK9 Inhibitors in a German Single-Center Clinical Practice: Real-World Treatment of Patients at High Cardiovascular Risk Over 68 by Hollstein, Tim, Kassner, Ursula, Grenkowitz, Thomas, Schumann, Friederike, Bobbert, Thomas, Steinhagen-Thiessen, Elisabeth

“…Aims Several lipid guidelines recommend the use of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) for patients at high/very high…”
Get full text

Treatment with PCSK9 inhibitors induces a more anti-atherogenic HDL lipid profile in patients at high cardiovascular risk by Ingueneau, Cécile, Hollstein, Tim, Grenkowitz, Thomas, Ruidavets, Jean-Bernard, Kassner, Ursula, Duparc, Thibaut, Combes, Guillaume, Perret, Bertrand, Genoux, Annelise, Schumann, Friederike, Bobbert, Thomas, Steinhagen-Thiessen, Elisabeth, Martinez, Laurent O.

“…Proprotein Convertase Subtilisin/Kexin type 9 inhibitors (PCSK9-I) have been reported to cause a moderate increase in high-density lipoprotein (HDL)…”
Get full text

Statinintoleranz und statinassoziierte Muskelschmerzen by Stürzebecher, Paulina Elena, Schumann, Friederike, Kassner, Ursula, Laufs, Ulrich

“…Zusammenfassung Statine gehören zu den bestuntersuchten Medikamenten. Aufgrund der umfangreichen Evidenz in Bezug auf Wirksamkeit und Sicherheit gehören sie…”
Get full text

Die Lysosomale saure Lipase-Defizienz diagnostizieren und behandeln by Kassner, Ursula, Haberbosch, Linus, Schumann, Friederike

“…Bei Neugeborenen mit schwerer Gedeihstörung, gastrointestinalen Symptomen und Hepatosplenomegalie sowie bei Kindern und Erwachsenen mit erniedrigtem HDL-C,…”
Get full text

HIV-Infektion und Lipidentgleisung — Gründe und Gegenmaßnahmen by Hollstein, Tim, Schumann, Friederike, Kassner, Ursula

“…Die Infektion mit dem Humanen Immundefizienz-Virus (HIV) führt zu einer bedeutenden Erhöhung des kardiovaskulären Risikos. Im folgenden CME-Kurs erfahren Sie,…”
Get full text

HIV-Infektion und Lipidentgleisung — Gründe und Gegenmaßnahmen: Kardiovaskuläre Erkrankungen by Hollstein, Tim, Schumann, Friederike, Kassner, Ursula

“…Die Infektion mit dem Humanen Immundefizienz-Virus (HIV) führt zu einer bedeutenden Erhöhung des kardiovaskulären Risikos. Im folgenden CME-Kurs erfahren Sie,…”
Get full text

Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®) by Kamm, Christoph, Schümann, Friederike, Mix, Eilhard, Benecke, Reiner

Get full text